[Mechanism of uricosuric action of benzbromaron].
作者信息
Politta G, Berthoud S, Gaudin G, Chavaz A, Fabre J
出版信息
Schweiz Rundsch Med Prax. 1973 Oct 30;62(44):1345-50.
PMID:4753055
Abstract
摘要
相似文献
1
[Mechanism of uricosuric action of benzbromaron].
Schweiz Rundsch Med Prax. 1973 Oct 30;62(44):1345-50.
2
Nature of the uricosuric action of benziodarone.苯碘达隆促尿酸排泄作用的性质。
Am J Physiol. 1973 Jun;224(6):1440-9. doi: 10.1152/ajplegacy.1973.224.6.1440.
3
[Uricosuric effect of benzbromaronum on a model of pyrazine amide-induced hyperuricemia].
Med Klin. 1970 Aug 1;65(32):1448-50.
4
[Benzbromarone in the treatment of hyperuricemias].
Minerva Med. 1975 Mar 7;66(17):783-800.
5
[Benzbromaron in the treatment of hyperuricemia].
Schweiz Rundsch Med Prax. 1973 Oct 30;62(44):1337-44.
6
Uricosuric effect of benziodarone in man and laboratory animals: a comparative study.
Am J Physiol. 1973 Jun;224(6):1431-9. doi: 10.1152/ajplegacy.1973.224.6.1431.
7
[Effect of furosemide on the transport of organic substances in the kidneys].
Biull Eksp Biol Med. 1977 Oct;84(10):436-8.
8
The pharmacology of the hypouricemic effect of benzbromarone.
Adv Exp Med Biol. 1977;76B:328-33. doi: 10.1007/978-1-4684-3285-5_49.
9
[Effect of benzbromarone in uricemia and uricosuria].
Med Welt. 1972 Jan 22;23(4):133-6.
10
Renal handling of uric acid in man.人体中尿酸的肾脏处理
Ann Clin Lab Sci. 1982 Jan-Feb;12(1):73-7.
引用本文的文献
1
A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?苯溴马隆治疗痛风的获益-风险评估。其退市符合患者的最大利益吗？
Drug Saf. 2008;31(8):643-65. doi: 10.2165/00002018-200831080-00002.
2
Drug interactions with urate excretion in man.人体中药物与尿酸排泄的相互作用。
Eur J Clin Pharmacol. 1987;32(5):499-502. doi: 10.1007/BF00637677.
3
Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia.苯溴马隆：其药理特性及在痛风和高尿酸血症治疗中的应用综述
Drugs. 1977 Nov;14(5):349-66. doi: 10.2165/00003495-197714050-00002.
Zotero 插件